IP Library › Granted Patent US 10,466,508
Granted Patent B2
US 10,466,508 · App. 15/743,158 · Granted Nov 5, 2019

Ophthalmic device with improved amplitude variation cell

Inventors: Jean-Paul Cano (Charenton le Pont, FR); Jerome Ballet (Charenton le Pont, FR); David Escaich (Charenton le Pont, FR); Stephane Perrot (Charenton le Pont, FR); Claudine Biver (Charenton le Pont, FR); Fabien Berit Debat (Charenton le Pont, FR); Samuel Archambeau (Charenton le Pont, FR); Sylvie Vinsonneau (Charenton le Pont, FR)
Assignee: Essilor International
G02C7/101G02B5/23G02C7/102G02F1/15G02B5/223G02F1/0018G02F1/0063G02F1/153
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,466,508
App. No.
15/743,158
Granted
Nov 5, 2019
Kind
B2
Abstract

The invention relates to an ophthalmic device including an electrically controllable amplitude variation cell, in particular an electrochromic transmission variation cell. More particularly, the cell ( 3 ) comprises a main convex surface on the front. This arrangement makes it possible for the cell to process a lateral luminous flux (RP), unlike cells in the prior art ( 1 AA).

Claims (16)

1. An ophthalmic device comprising:

a cell of electrically controllable variable amplitude, the cell comprising at least a first transparent layer front-side and a second transparent layer back-side, the first and second layers defining therebetween a cavity, the first transparent layer having a main surface, exterior to the cavity, that is convex,

wherein the ophthalmic device includes at least one transparent insert, adhesively bonded to the first and/or second transparent layers of the cell and has an optical power chosen according to an ophthalmic prescription of a wearer of the device.

2. The device as claimed in claim 1 , wherein the cavity has, to within 30%, a constant spacing between said first and second layers.

3. The device as claimed in claim 1 , wherein the cavity is closed and filled with an electrochromic solution, connected to a processing circuit for setting an optical amplitude of the cell.

4. The device as claimed in claim 1 , wherein a face internal to the cavity of at least one of the transparent layers is covered with a conductive coating made of indium tin oxide.

5. The device as claimed in claim 1 , wherein the cell is of electrically controllable variable transmission in order to be, in the visible spectrum:

higher than 80% in a first state, and

lower than 30% in a second state.

6. The device as claimed in claim 5 , wherein the cell is of electrically controllable variable transmission in order to be, in the visible spectrum:

higher than the 85%, in the first state.

7. The device as claimed in claim 5 , wherein the cell is of electrically controllable variable transmission in order to be, in the visible spectrum:

lower than 18%, in the second state.

8. The device as claimed in claim 1 , wherein the cell is connected to a control circuit via a connecting element of thickness smaller than 5 μm and of width smaller than 1000 μm.

9. The device as claimed in claim 1 , furthermore including a frame comprising at least one aperture housing said cell and having a convex curvature front-side, wherein the convex main surface of said transparent layer has a curvature corresponding to the curvature of the frame.

10. The device as claimed in claim 1 , wherein the cell includes at least one transparent layer of curvature chosen to endow the cell with an optical power respecting an ophthalmic prescription of a wearer of the device.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 5, 2018
From: CANO, JEAN-PAUL; BALLET, JEROME; ESCAICH, DAVID; PERROT, STEPHANE; BIVER, CLAUDINE; BERIT DEBAT, FABIEN; ARCHAMBEAU, SAMUEL; VINSONNEAU, SYLVIE
To: ESSILOR INTERNATIONAL
Reel/Frame 045105/0848 →
Priority Claims (1)
FR 15 56613 · Jul 10, 2015 · national
Continuity (1)
Related Publication 20180210233A1 · Jul 26, 2018